Our findings are comparable with those of a previous study (Gandhirajan et al., 2013), suggesting that the inhibition of NFAT–Egr-3 interaction by BTP2 may at least in part suppress the inflammation induced by DCS. The gene discussed is EGR3; the disease is Dorfman-Chanarin disease.